DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mavoglurant
Mavoglurant
Metabotropic Glutamate Receptors
Draft COMP Agenda 16-18 January 2018
Hierarchical Mechanistic Modelling of Clinical Pharmacokinetic Data
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Title Page Metabolism and Disposition of the Metabotropic Glutamate
Emerging Preclinical Pharmacological Targets for Parkinson's Disease
Rescue of Fmr1ko Phenotypes with Mglur5 Inhibitors MRZ-8456
Understanding Exposure-Receptor Occupancy Relationships For
Regional Brain Mglu5 Receptor Occupancy Following Single Oral Doses of Mavoglurant As Measured by [11C]-ABP688 PET Imaging in Healthy Volunteers
Drug Metabolism Letters, 2019, 13, 53-63
Targeting VGLUT Machinery: Implications on Mglur5 Signaling and Behavior
Fragile X Targeted Pharmacotherapy: Lessons Learned and Future Directions Craig A
Analysis of Positive and Negative Allosteric Modulation In
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Calcium Regulation of Cell-Cell Communication and Extracellular Signaling
Mavoglurant in Fragile X Syndrome: Results from Two Phase II Randomized, Double-Blind Trials
Pharmacology of Mavoglurant, a Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Kirstie a Bennett, John a Christo
Top View
AHRQ Healthcare Horizon Scanning System – Status Update Horizon
AHRQ Healthcare Horizon Scanning System – Status Update
Original Article Increased Glutamic Acid Decarboxylase Expression in the Hippocampus Impairs Learning and Memory in Fmr1 Knockout Mice
Metabotropic Glutamate Receptors Molecular Pharmacology
Metabotropic Glutamate Receptors Review
Analysis of Clinical Global Impression-Improvement Source Data from a Double-Blind Therapeutic Study Followed by an Open-Label, Long-Term Extension Study Donald B
Effect of the Mglur5-NAM Basimglurant on Behavior In
[18F]FPEB Binding to Metabotropic Glutamate Receptor Subtype
MPEP, a Metabotropic Glutamate Receptor 5 (Mglur5) Negative Allosteric Modulator, Protects from Hepatic Ischemic Injury Both in Vitro and Ex Vivo
Neuroprotective Compound Library (96-Well)
Bioactive Compound Library Plus (96-Well)
Improved Methods in the Collection of Biological Samples for Complex Occupational and Environmental Settings
Roles of Glutamate Receptors in Parkinson's Disease
Results of a Randomized, Double-Blind Study Background
Product Data Sheet
Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5
Drug Repurposing Compound Library Plus (96-Well)
Neurological Disease
Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Mglu5 Negative Allosteric Modulator in Clinical Development for Depression
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
312613629-Oa
Drug Repurposing Compound Library (96-Well)
Molecular Biomarkers in Fragile X Syndrome
Draft COMP Agenda 6-8 December 2016
Positional Isomers of Bispyridine Benzene Derivatives Induce Efficacy
The Role of Water and Protein Flexibility in the Structure-Based Virtual Screening of Allosteric GPCR Modulators: an Mglu5 Recep
Mavoglurant in Fragile X Syndrome: Results of Two Open-Label